4URK image
Deposition Date 2014-06-30
Release Date 2014-10-22
Last Version Date 2024-01-10
Entry Detail
PDB ID:
4URK
Keywords:
TRANSFERASE
Title:
PI3Kg in complex with AZD6482
Biological Source:
Source Organism:
HOMO SAPIENS (Taxon ID: 9606)
Host Organism:
SPODOPTERA FRUGIPERDA
Method Details:
Experimental Method:
X-RAY DIFFRACTION
Resolution:
2.90 Å
R-Value Free:
0.30
R-Value Work:
0.25
R-Value Observed:
0.25
Space Group:
C 1 2 1
4URK validation report
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM
Gene (Uniprot):PIK3CG
Chain IDs:A
Chain Length:966
Number of Molecules:1
Biological Source:HOMO SAPIENS
UniProt ID:P48736 Pfam ID:PF00794, PF00792, PF00613, PF00454 EC:2.7.1.137
Ligand Molecules
A82
Primary Citation
Discovery of 9-(1-Phenoxyethyl)-2-Morpholino-4-Oxo-Pyrido[1, 2-A]Pyrimidine-7-Carboxamides as Oral Pi3Kbeta Inhibitors, Useful as Antiplatelet Agents.
Bioorg.Med.Chem.Lett. 24 3936 ? (2014)
PMID: 25042253 DOI: 10.1016/J.BMCL.2014.07.007

Abstact

Optimization of AZD6482 (2), the first antiplatelet PI3Kβ inhibitor evaluated in man, focused on improving the pharmacokinetic profile to a level compatible with once daily oral dosing as well as achieving adequate selectivity towards PI3Kα to minimize the risk for insulin resistance. Structure-based design and optimization of DMPK properties resulted in (R)-16, a novel, orally bioavailable PI3Kβ inhibitor with potent in vivo anti-thrombotic effect with excellent separation to bleeding risk and insulin resistance.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
4URK